Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection

被引:57
|
作者
Quan, Fu-Shi [3 ]
Kim, Min-Chul [4 ,5 ]
Lee, Byeong-Jae [4 ,5 ]
Song, Jae-Min [6 ]
Compans, Richard W. [4 ,5 ]
Kang, Sang-Moo [1 ,2 ]
机构
[1] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA
[2] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[3] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul 130701, South Korea
[4] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[6] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea
关键词
Influenza; Virus-like particles; Neuraminidase; Protection; VIRUS-LIKE PARTICLES; INTRAVIRIONIC ANTIGENIC-COMPETITION; EXPRESSING H5 HEMAGGLUTININ; BROADENED IMMUNE-RESPONSE; A VIRUS; AVIAN INFLUENZA; LETHAL INFLUENZA; DENDRITIC CELLS; VIRAL NEURAMINIDASE; ANTIBODY-RESPONSE;
D O I
10.1016/j.virol.2012.05.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Influenza virus like particles (VLPs) containing hemagglutinin were previously demonstrated to induce protection against the homologous strains. However, little information is available on the protective role of neuraminidase (NA), the second major glycoprotein. In this study, we developed VLPs (NA VLPs) containing NA and M1 derived from A/PR/8/34 (H1N1) influenza virus, and investigated their ability to induce protective immunity. Intranasal immunization with NA VLPs induced serum antibody responses to H1N1 and H3N2 influenza A viruses as well as significant neuraminidase inhibition activity. Importantly, mice immunized with NA VLPs were 100% protected against lethal infection by the homologous A/PR/8/34 (H1N1) as well as heterosubtypic A/Philippines/82 (H3N2) virus, although body weight loss was observed after lethal challenge with heterosubtypic H3N2 virus. The present study therefore provides evidence that influenza VLPs containing M1 and NA are capable of inducing immunity to homologous as well as antigenically distinct influenza A virus strains. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 135
页数:9
相关论文
共 50 条
  • [31] SipD and IpaD induce a cross-protection against Shigella and Salmonella infections
    Jneid, Bakhos
    Rouaix, Audrey
    Feraudet-Tarisse, Cecile
    Simon, Stephanie
    PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (05): : 1 - 18
  • [32] Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses
    Kamijuku, H.
    Nagata, Y.
    Jiang, X.
    Ichinohe, T.
    Tashiro, T.
    Mori, K.
    Taniguchi, M.
    Hase, K.
    Ohno, H.
    Shimaoka, T.
    Yonehara, S.
    Odagiri, T.
    Tashiro, M.
    Sata, T.
    Hasegawa, H.
    Seino, K-i
    MUCOSAL IMMUNOLOGY, 2008, 1 (03) : 208 - 218
  • [33] Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection
    Kim, Yu-Jin
    Ko, Eun-Ju
    Kim, Min-Chul
    Lee, Yu-Na
    Kim, Ki-Hye
    Jung, Yu-Jin
    Kang, Sang-Moo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 393 - 398
  • [34] Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
    Lee, Young-Tae
    Ko, Eun-Ju
    Lee, Youri
    Kim, Ki-Hye
    Kim, Min-Chul
    Lee, Yu-Na
    Kang, Sang-Moo
    PLOS ONE, 2018, 13 (01):
  • [35] Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo
    Epstein, Suzanne L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2018, 187 (12) : 2603 - 2614
  • [36] Cross-Protection of BCG Vaccination in Influenza Infection: Trained Adaptive Immunity?
    Tran, K.
    Downey, J.
    Divangahi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [37] Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages
    Page, Caroline K.
    Shepard, Justin D.
    Ray, Sean D.
    Ferguson, James A.
    Rodriguez, Alesandra J.
    Han, Julianna
    Jacob, Joel C.
    Rowe-Haas, Dawne K.
    Akinpelu, Jasmine Y.
    Friedman, Lilach M.
    Hertz, Tomer
    Ward, Andrew B.
    Tompkins, Stephen M.
    SCIENCE ADVANCES, 2025, 11 (13):
  • [38] Sequential Immunizations with Influenza Neuraminidase Protein Followed by Peptide Nanoclusters Induce Heterologous Protection
    Song, Wen-Wen
    Wan, Mu-Yang
    She, Jia-Yue
    Zhao, Shi-Long
    Liu, De-Jian
    Chang, Hai-Yan
    Deng, Lei
    VIRUSES-BASEL, 2024, 16 (01):
  • [39] Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models
    Park, Su-Jin
    Kim, Eun-Ha
    Pascua, Philippe Noriel Q.
    Kwon, Hyeok-Il
    Lim, Gyo-Jin
    Decano, Arun
    Kim, Se Mi
    Song, Man Ki
    Shin, Eui-Cheol
    Choi, Young-Ki
    JOURNAL OF GENERAL VIROLOGY, 2014, 95 : 793 - 798
  • [40] Cross-protection and reassortment studies with avian H2 influenza viruses
    N. V. Kaverin
    Y. A. Smirnov
    E. A. Govorkova
    I. A. Rudneva
    A. K. Gitelman
    A. S. Lipatov
    N. L. Varich
    S. S. Yamnikova
    N. V. Makarova
    R. G. Webster
    D. K. Lvov
    Archives of Virology, 2000, 145 : 1059 - 1066